You are here: Welcome to the MPKB » Welcome to the MPKB » Diseases » Chronic Lyme disease
Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revisionBoth sides next revision
home:diseases:lyme [08.02.2019] – [Other treatments] sallieqhome:diseases:lyme [08.02.2019] – [Disulfiram] sallieq
Line 81: Line 81:
 [[https://clinicaltrials.gov/ct2/show/NCT03891667|Study to examine the safety of disulfiram among patients with post-treatment Lyme disease Sx]] [[https://clinicaltrials.gov/ct2/show/NCT03891667|Study to examine the safety of disulfiram among patients with post-treatment Lyme disease Sx]]
  
-Screening to identify potent drug candidates that can target the Borrelia persisters.(({{pubmed>long:27103785}}))+Screening to identify potent candidate drugs that can target the Borrelia persisters.(({{pubmed>long:27103785}}))
  
 +=== MP patient to try ===
  
 +<blockquote>My doc just prescribed this for me but with a big warning to ramp VERY slowly due to immunopathology, IP/ Herx can be powerful.
 +I have not filled the script yet but will update my progress thread if/ when I embark on this method.</blockquote>
 ===== Role of infection ===== ===== Role of infection =====
  
home/diseases/lyme.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.